Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation
Authors:
Open Access
- 1 November 2017
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 135 (11) , 1141-1146
Abstract
Trachoma, a chronic conjunctivitis caused by Chlamydia trachomatis, is the leading infectious cause of blindness worldwide, although impressive strides toward elimination are being achieved.1 The World Health Organization (WHO)2 has set a goal of elimination of trachoma as a public health problem by 2020. Elimination has been defined as a follicular trachoma (TF) prevalence less than 5% among children aged 1 to 9 years at the district level and as a trachomatous trichiasis (TT) case unknown to the health system prevalence less than 2 cases per 1000 population 15 years and older at the district level.3 As more endemic districts within countries reach the elimination goal, they must undergo surveillance surveys for potential reemergence. The WHO recommends that at least 2 years after cessation of mass drug administration (MDA) a surveillance prevalence survey should be undertaken in the district to reconfirm a less than 5% level of TF and a sustainable reduction of TT.3Keywords
This publication has 12 references indexed in Scilit:
- Defining Seropositivity Thresholds for Use in Trachoma Elimination StudiesPLOS Neglected Tropical Diseases, 2017
- The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS StudyPLOS Neglected Tropical Diseases, 2016
- Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma ProgramPLOS Neglected Tropical Diseases, 2016
- Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District SurveyPLOS Neglected Tropical Diseases, 2016
- TrachomaThe Lancet, 2014
- CT694 and pgp3 as Serological Tools for Monitoring Trachoma ProgramsPLOS Neglected Tropical Diseases, 2012
- Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in TanzaniaPLOS Neglected Tropical Diseases, 2011
- Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal studyThe Lancet, 2005
- Disappearance of Trachoma from Western NepalClinical Infectious Diseases, 2002
- A SIMPLE SYSTEM FOR THE ASSESSMENT OF TRACHOMA AND ITS COMPLICATIONS1987